| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bc5292a07e34d16eb1d033a16d3aec3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2017-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d332100bfc8a2fb5b653bd78ed66ddf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42043be11f432d050f7d8949bb3c33f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e59761ca8353882cd85c723e596ac12b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ecc0cf010ee4a45430c3d82d0e7069c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12df6188be6f62d88b20e318d7bc6ef3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dc6753d32ef3c22a5f5dfab2b51904c |
| publicationDate |
2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019209606-A1 |
| titleOfInvention |
Situ gelling compositions for the treatment or prevention of inflammation and tissue damage |
| abstract |
Described herein are in situ gelling compositions. The compositions include an anti-inflammatory polysaccharide and a gelling polymer, wherein the composition is a liquid prior to administration to a subject but converts to a gel upon administration to the subject. The compositions described herein have numerous applications with respect to the local treatment (reduction or prevention) of inflammation and/or tissue damage. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113499473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102022202547-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021025147-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023104843-A1 |
| priorityDate |
2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |